Moreover, we show in ALS mice that MCs number and trafficking into the spinal cord were downregulated by masitinib, a drug that modulates MCs activity via inhibition of c-Kit, LYN, and FYN kinases, with subsequent anti-inflammatory and neuroprotective effects in ALS [32, 47]. Here, LYN is linked to amyotrophic lateral sclerosis.